help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cagnacci, A.
Right arrow Articles by Melis, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cagnacci, A.
Right arrow Articles by Melis, G. B.

Journal of Clinical Endocrinology & Metabolism, Vol 74, 1396-1400, Copyright © 1992 by Endocrine Society

ARTICLES

Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women

A Cagnacci, R Soldani, PL Carriero, AM Paoletti, P Fioretti and GB Melis
Department of Reproductive Medicine, University of California-San Diego, La Jolla 92093-0802.

The impact of a 3-month continuous administration of transdermal estradiol (E2-TTS 50; 50 micrograms/day) or oral conjugated estrogen (CE; 0.625 mg/day) on glucose and lipid metabolism was investigated in two groups (n = 15/group) of postmenopausal women. Fasting levels of glucose, insulin, and C-peptide; C-peptide/insulin ratio (index of hepatic insulin clearance); and their responses to a 75-g oral glucose tolerance test (OGTT) were evaluated before and after 3 months of continuous estrogen administration. E2-TTS 50 modified carbohydrate metabolism, decreasing fasting insulin levels (P less than 0.01) and increasing the pancreatic islet response to glucose challenges, as indicated by an increased integrated value of the C-peptide curve associated with OGTT (P less than 0.05). Despite greater C-peptide secretion, integrated peripheral insulin after OGTT was decreased (P less than 0.05). The resulting increase in the integrated curve of the molar C-peptide/insulin ratio (P less than 0.01) indicated elevated hepatic insulin clearance after E2-TTS 50 administration. CE treatment did not modify carbohydrate metabolism, except for reducing fasting glucose levels (P less than 0.01). Neither therapy modified lipid metabolism, but a slight increase in circulating triglycerides (P less than 0.01) was observed during CE administration. Our data show that the addition of low doses of natural estrogens does not negatively influence glucose and lipid metabolism in postmenopausal women. By contrast, reversal of postmenopausal hypoestrogenism to early follicular phase estrogenic values with E2-TTS 50 administration seems to exert a beneficial effect on glucose metabolism by increasing hepatic insulin clearance.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
L. Hoeg, C. Roepstorff, M. Thiele, E. A. Richter, J. F. P. Wojtaszewski, and B. Kiens
Higher intramuscular triacylglycerol in women does not impair insulin sensitivity and proximal insulin signaling
J Appl Physiol, September 1, 2009; 107(3): 824 - 831.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. J. Toth, B. C. Cooper, R. E. Pratley, A. Mari, D. E. Matthews, and P. R. Casson
Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion
Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1035 - E1045.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. E. Van Pelt, R. S. Schwartz, and W. M. Kohrt
Insulin Secretion and Clearance after Subacute Estradiol Administration in Postmenopausal Women
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 484 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. W. Mankhey, C. C. Wells, F. Bhatti, and C. Maric
17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R769 - R777.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D.-J. Kim and E. Barrett-Connor
Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the rancho bernardo study.
Diabetes Care, March 1, 2006; 29(3): 618 - 624.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
L. M C. S M Leao, M. P. C Duarte, D. M. B Silva, P. R. V Bahia, C. M. Coeli, and M. L. F. de Farias
Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study
Eur. J. Endocrinol., January 1, 2006; 154(1): 131 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. R. Batista, M. S. Smith, W. L. Snead, C. C. Connolly, D. B. Lacy, and M. C. Moore
Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R1064 - R1073.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. K. Sites, G. D. L'Hommedieu, M. J. Toth, M. Brochu, B. C. Cooper, and P. A. Fairhurst
The Effect of Hormone Replacement Therapy on Body Composition, Body Fat Distribution, and Insulin Sensitivity in Menopausal Women: A Randomized, Double-Blind, Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2701 - 2707.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Rossi, G. Origliani, and M. G. Modena
Transdermal 17-{beta}-Estradiol and Risk of Developing Type 2 Diabetes in a Population of Healthy, Nonobese Postmenopausal Women
Diabetes Care, March 1, 2004; 27(3): 645 - 649.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Cagnacci, A. M. Paoletti, A. Renzi, M. Orru, M. Pilloni, G. B. Melis, and A. Volpe
Glucose Metabolism and Insulin Resistance in Women with Polycystic Ovary Syndrome during Therapy with Oral Contraceptives Containing Cyproterone Acetate or Desogestrel
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3621 - 3625.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. E. Van Pelt, W. S. Gozansky, R. S. Schwartz, and W. M. Kohrt
Intravenous estrogens increase insulin clearance and action in postmenopausal women
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E311 - E317.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Okada, S. Nomura, Y. Ikoma, E. Yamamoto, T. Ito, T. Mitsui, K. Tamakoshi, and S. Mizutani
Effects of Postmenopausal Hormone Replacement Therapy on HbA1c Levels
Diabetes Care, April 1, 2003; 26(4): 1088 - 1092.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
A. M. Kanaya, D. Herrington, E. Vittinghoff, F. Lin, D. Grady, V. Bittner, J. A. Cauley, and E. Barrett-Connor
Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial
Ann Intern Med, January 7, 2003; 138(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
V. Jayagopal, E. S. Kilpatrick, P. E. Jennings, D. A. Hepburn, and S. L. Atkin
Biological Variation of Homeostasis Model Assessment-Derived Insulin Resistance in Type 2 Diabetes
Diabetes Care, November 1, 2002; 25(11): 2022 - 2025.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Cagnacci, A. M. Paoletti, A. Zanni, S. Arangino, G. Ibba, M. Orru, G. B. Melis, and A. Volpe
Raloxifene Does Not Modify Insulin Sensitivity and Glucose Metabolism in Postmenopausal Women
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4117 - 4121.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Cucinelli, L. Soranna, D. Romualdi, G. Muzj, S. Mancuso, and A. Lanzone
The Effect of Raloxifene on Glyco-Insulinemic Homeostasis in Healthy Postmenopausal Women: A Randomized Placebo-Controlled Study
J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4186 - 4192.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. E. Campbell and M. A. Febbraio
Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake
Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1139 - E1146.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Y. Zhang, B. V. Howard, L. D. Cowan, J. Yeh, C. F. Schaefer, R. A. Wild, W. Wang, and E. T. Lee
The Effect of Estrogen Use on Levels of Glucose and Insulin and the Risk of Type 2 Diabetes in American Indian Postmenopausal Women : The Strong Heart Study
Diabetes Care, March 1, 2002; 25(3): 500 - 504.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. S. Ryan, B. J. Nicklas, and D. M. Berman
Hormone Replacement Therapy, Insulin Sensitivity, and Abdominal Obesity in Postmenopausal Women
Diabetes Care, January 1, 2002; 25(1): 127 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Ferrara, A. J. Karter, L. M. Ackerson, J. Y. Liu, and J. V. Selby
Hormone Replacement Therapy Is Associated With Better Glycemic Control in Women With Type 2 Diabetes: The Northern California Kaiser Permanente Diabetes Registry
Diabetes Care, July 1, 2001; 24(7): 1144 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. M. Oleksik, T. Duong, N. Pliester, G. Asma, C. Popp-Snijders, and P. Lips
Effects of the Selective Estrogen Receptor Modulator, Raloxifene, on the Somatotropic Axis and Insulin-Glucose Homeostasis
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2763 - 2768.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. E. Friday, C. Dong, and R. U. Fontenot
Conjugated Equine Estrogen Improves Glycemic Control and Blood Lipoproteins in Postmenopausal Women with Type 2 Diabetes
J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 48 - 52.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Vehkavaara, J. Westerbacka, T. Hakala-Ala-Pietilä, A. Virkamäki, O. Hovatta, and H. Yki-Järvinen
Effect of Estrogen Replacement Therapy on Insulin Sensitivity of Glucose Metabolism and Preresistance and Resistance Vessel Function in Healthy Postmenopausal Women
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4663 - 4670.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. C. Duncan, H. Lyall, R.N. Roberts, J. R. Petrie, M. J. Perera, S. Monaghan, D. M. Hart, J. M. C. Connell, and M. A. Lumsden
The Effect of Estradiol and a Combined Estradiol/Progestagen Preparation on Insulin Sensitivity in Healthy Postmenopausal Women
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2402 - 2407.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
A. Cagnacci, A.M. Paoletti, S. Arangino, G.B. Melis, and A. Volpe
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
Hum. Reprod., April 1, 1999; 14(4): 893 - 897.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Cagnacci, L. Rovati, A. Zanni, S. Malmusi, F. Facchinetti, and A. Volpe
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1355 - H1360.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. P. Bilezikian, A. Morishima, J. Bell, and M. M. Grumbach
Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency
N. Engl. J. Med., August 27, 1998; 339(9): 599 - 603.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Cagnacci, E. Mallus, F. Tuveri, R. Cirillo, A. M. Setteneri, and G. B. Melis
Effect of Tibolone on Glucose and Lipid Metabolism in Postmenopausal Women
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 251 - 253.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
The Writing Group for the PEPI Trial, V. T. Miller, J. LaRosa, V. Barnabei, C. Kessler, G. Levin, A. Smith-Roth, M. Griffin, D. B. Stoy, T. Bush, et al.
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
JAMA, January 18, 1995; 273(3): 199 - 208.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1992 by The Endocrine Society